The Benefit of Early and Frequent Antitumor Necrosis Factor-Alpha Trough Level Determination in Very Early-Onset Inflammatory Bowel Disease

A patient with infantile-onset Crohn's disease had a partial response to corticosteroid therapy that worsened on its tapering, leading to treatment with antitumor necrosis factor-alpha monoclonal antibody therapy. Infliximab rapidly cleared before administration of the third accelerated inducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillmore, Taylor, Jimenez-Rivera, Carolina, Mack, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624466/
https://www.ncbi.nlm.nih.gov/pubmed/37928229
http://dx.doi.org/10.14309/crj.0000000000001197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624466/
https://www.ncbi.nlm.nih.gov/pubmed/37928229
http://dx.doi.org/10.14309/crj.0000000000001197

Ejemplares similares